Cargando…
Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab
AIM: The aim of this study was to add robustness and provide further evidence on the bioequivalence, safety and immunogenicity between MB02 and reference bevacizumab. No similar study has been performed before with a biosimilar monoclonal antibody. METHODS: Population analysis by pooling data from t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622740/ https://www.ncbi.nlm.nih.gov/pubmed/37920875 http://dx.doi.org/10.1002/prp2.1139 |